[Recommendations for the standardization of growth hormone assays]. 2004

M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
CHU de Grenoble, Paris.

The diagnosis of growth hormone (GH) deficiency is based on the GH biological response to pharmacological stimulation tests. The cut-off value defining normality is the same whatever the GH assay used. In a group of the French Society for Clinical Biology (SFBC), we have evaluated whether differences between the GH concentrations obtained with the 9 commercial GH assays available in France exist or not. The study samples consisted of 72 serum pools and serial dilutions of the recombinant GH 22 kDa international standard, IS 98/574. These dilutions were performed by using 3 different diluents: the specific diluent provided by the manufacturers and thus different from one assay to another, serum without GH and heparin plasma without GH. Despite being calibrated against the same international standard, the different assays proposed variable conversion factors between microg and mIU, and we decided to express the results in mIU. The GH concentrations obtained for the 72 serum pools with the 9 assays were highly correlated, but absolute concentrations were significantly different from one assay to another. In particular, the ratio between the concentrations measured with both assays giving the lowest and highest concentration in the same sample respectively was about 50%. In the recovery test executed by adding the international standard, the slope of the regression curve describing the relationship between expected and measured concentrations was different of 1 in all but one assay. Furthermore, for a given assay and a given expected concentration, the measured values were sometimes different by up to 30% depending on the diluent used. These results led us to advise the manufacturers to calibrate their assays against the recombinant GH international standard, IS 98/574, to take into account the matrix effect detected in our study and to use the official conversion factor of 3 mIU/microg. Waiting for this new calibration, it is recommended that the results should be expressed in mIU/L and that serum samples should be used for the measurement of GH instead of plasma samples.

UI MeSH Term Description Entries
D001774 Blood Chemical Analysis An examination of chemicals in the blood. Analysis, Blood Chemical,Chemical Analysis, Blood,Analyses, Blood Chemical,Blood Chemical Analyses,Chemical Analyses, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
November 1995, The Journal of clinical endocrinology and metabolism,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
May 1998, Annals of clinical biochemistry,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
April 2011, Clinical chemistry,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
January 1990, Acta paediatrica Scandinavica. Supplement,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
September 2007, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
July 2007, Hepatology (Baltimore, Md.),
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
December 2008, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
December 2011, Clinical chemistry,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
November 1977, Pediatrics,
M Bayle, and D Chevenne, and B Dousset, and N Lahlou, and Y Le Bouc, and C Massart, and M Noel, and D Porquet, and J-P Salles, and C Sault, and J-C Souberbielle, and
April 1974, Journal of the Royal College of Physicians of London,
Copied contents to your clipboard!